Interventions in Congenital Heart Disease: A Review of Recent Developments: Part II

References

• Ooi YK, Kelleman M, Ehrlich A, et al. Transcatheter versus surgical closure of atrial septal defects in children: a value comparison. JACC Cardiovasc Interv. 2016;9(1):79–86. doi:https://doi.org/10.1016/j.jcin.2015.09.028. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Du ZD, Hijazi ZM, Kleinman CS, Silverman NH, Larntz K. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J Am Coll Cardiol. 2002;39(11):1836–1844. doi:https://doi.org/10.1016/s0735-1097(02)01862-4. [ published Online First: Epub Date].
   PubMed Web of Science ®Google Scholar
• Villablanca PA, Briston DA, Rodés-Cabau J, et al. Treatment options for the closure of secundum atrial septal defects: a systematic review and meta-analysis. Int J Cardiol. 2017;241:149–155. doi:https://doi.org/10.1016/j.ijcard.2017.03.073. [ published Online First: Epub Date].
   PubMed Web of Science ®Google Scholar
• King TD, Thompson SL, Steiner C, Mills NL. Secundum atrial septal defect. Nonoperative closure during cardiac catheterization. JAMA. 1976;235(23):2506–2509. doi:https://doi.org/10.1001/jama.1976.03260490024013.
   Web of Science ®Google Scholar
• Nassif M, Abdelghani M, Bouma BJ, et al. Historical developments of atrial septal defect closure devices: what we learn from the past. Expert Rev Med Devices. 2016;13(6):555–568. doi:https://doi.org/10.1080/17434440.2016.1182860. [ published Online First: Epub Date].
   PubMed Web of Science ®Google Scholar
• Turner DR, Owada CY, Sang CJ Jr., Khan M, Lim DS. Closure of secundum atrial septal defects with the AMPLATZER septal occluder: a prospective, multicenter, post-approval study. Circ Cardiovasc Interv. 2017;10(8):e004212. doi:https://doi.org/10.1161/circinterventions.116.004212. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Omeish A, Hijazi ZM. Transcatheter closure of atrial septal defects in children & adults using the Amplatzer septal occluder. J Interv Cardiol. 2001;14(1):37–44. doi:https://doi.org/10.1111/j.1540-8183.2001.tb00709.x. [ published Online First: Epub Date].
   Google Scholar
• Fraisse A, Latchman M, Sharma SR, et al. Atrial septal defect closure: indications and contra-indications. J Thorac Dis. 2018;10(Suppl 24):S2874–s81. doi:https://doi.org/10.21037/jtd.2018.08.111. [ published Online First: Epub Date].
   Google Scholar
• Haddad RN, Khraiche D, Bonnet D, Meot M, Malekzadeh-Milani S. Preliminary experience with the new Amplatzer™ Trevisio™ delivery system in transcatheter atrial septal defect closures in children. Front Pediatr. 2021;9:641742. doi:https://doi.org/10.3389/fped.2021.641742.
   Web of Science ®Google Scholar
• Haas NA, Soetemann DB, Ates I, et al. Closure of secundum atrial septal defects by using the occlutech occluder devices in more than 1300 patients: the IRFACODE project: a retrospective case series. Catheter Cardiovasc Interv. 2016;88(4):571–581. doi:https://doi.org/10.1002/ccd.26497. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Apostolopoulou SC, Tsoutsinos A, Laskari C, Kiaffas M, Rammos S. Large single centre experience with the Cera™ and CeraFlex™ occluders for closure of interatrial communications: usefulness of the flexible rotation feature. Cardiovasc Interv Ther. 2018;33(1):70–76. doi:https://doi.org/10.1007/s12928-016-0440-y. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Bhattacharjya S, Pillai LS, Doraiswamy V, et al. Prospective concurrent head-to head comparison of three different types of nitinol occluder device for transcatheter closure of secundum atrial septal defects. EuroIntervention. 2019;15(4):e321–e28. doi:https://doi.org/10.4244/eij-d-18-01016. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• McElhinney DB, Quartermain MD, Kenny D, Alboliras E, Amin Z. Relative risk factors for cardiac erosion following transcatheter closure of atrial septal defects: a case-control study. Circulation. 2016;133(18):1738–1746. doi:https://doi.org/10.1161/circulationaha.115.019987. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Auriau J, Bouvaist H, Aaberge L, et al. Cardiac erosions after transcatheter atrial septal defect closure with the occlutech figulla flex device. JACC Cardiovasc Interv. 2019;12(14):1397–1399. doi:https://doi.org/10.1016/j.jcin.2019.03.005. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• De Hemptinne Q, Horlick EM, Osten MD, et al. Initial clinical experience with the GORE(®) CARDIOFORM ASD occluder for transcatheter atrial septal defect closure. Catheter Cardiovasc Interv. 2017;90(3):495–503. doi:https://doi.org/10.1002/ccd.26907. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Gillespie MJ, Javois AJ, Moore P, Forbes T, Paolillo JA. Use of the GORE® CARDIOFORM septal occluder for percutaneous closure of secundum atrial septal defects: results of the multicenter U.S. IDE trial. Catheter Cardiovasc Interv. 2020;95(7):1296–1304. doi:https://doi.org/10.1002/ccd.28814. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Sommer RJ, Love BA, Paolillo JA, et al. ASSURED clinical study: new GORE® CARDIOFORM ASD occluder for transcatheter closure of atrial septal defect. Catheter Cardiovasc Interv. 2020;95(7):1285–1295. doi:https://doi.org/10.1002/ccd.28728. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Kumar P, Orford JL, Tobis JM. Two cases of pericardial tamponade due to nitinol wire fracture of a gore septal occluder. Catheter Cardiovasc Interv. 2020;96(1):219–224. doi:https://doi.org/10.1002/ccd.28596. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Anderson JH, Adamson T, Migliati E, et al. Perforating the GORE® CARDIOFORM septal occluder and atrial septal defect occluder to gain access to the left atrium. Catheter Cardiovasc Interv. 2020;96(6):E660–e65. doi:https://doi.org/10.1002/ccd.28884. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Shi D, Kang Y, Zhang G, et al. Biodegradable atrial septal defect occluders: a current review. Acta Biomater. 2019;96:68–80. doi:https://doi.org/10.1016/j.actbio.2019.05.073. [ published Online First: Epub Date].
   PubMed Web of Science ®Google Scholar
• Li YF, Xie YM, Chen J, et al. Initial experiences with a novel biodegradable device for percutaneous closure of atrial septal defects: from preclinical study to first-in-human experience. Catheter Cardiovasc Interv. 2020;95(2):282–293. doi:https://doi.org/10.1002/ccd.28529. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Sigler M, Söderberg B, Schmitt B, Mellmann A, Bernhard J. Carag bioresorbable septal occluder (CBSO): histopathology of experimental implants. EuroIntervention. 2018;13(14):1655–1661. doi:https://doi.org/10.4244/eij-d-17-00006. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Soderberg B, Vaskelyte L, Gafoor S, et al. TCT-826 prospective single center first in human (FIH) clinical trial to evaluate the safety and effectiveness of a septal occluder with bioresorbable framework in patients with clinically significant atrial septum defect (ASD) or patent foramen ovale (PFO). J Am Coll Cardiol. 2016;68(18):B334. doi:https://doi.org/10.1016/j.jacc.2016.09.855. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Penny DJ, Vick GW 3rd. Ventricular septal defect. Lancet. 2011;377(9771):1103–1112. doi:https://doi.org/10.1016/s0140-6736(10)61339-6. [ published Online First: Epub Date].
   PubMed Web of Science ®Google Scholar
• Baumgartner H, De Backer J, Babu-Narayan SV, et al. 2020 ESC guidelines for the management of adult congenital heart disease. Eur Heart J. 2021;42(6):563–645. doi:https://doi.org/10.1093/eurheartj/ehaa554. [ published Online First: Epub Date].
   PubMed Web of Science ®Google Scholar
• Lock JE, Block PC, McKay RG, Baim DS, Keane JF. Transcatheter closure of ventricular septal defects. Circulation. 1988;78(2):361–368. doi:https://doi.org/10.1161/01.cir.78.2.361. [ published Online First: Epub Date].
   PubMed Web of Science ®Google Scholar
• Kalra GS, Verma PK, Dhall A, Singh S, Arora R. Transcatheter device closure of ventricular septal defects: immediate results and intermediate-term follow-up. Am Heart J. 1999;138(2 Pt 1):339–344. doi:https://doi.org/10.1016/s0002-8703(99)70122-5. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Sideris EB, Walsh KP, Haddad JL, Chen CR, Ren SG, Kulkarni H. Occlusion of congenital ventricular septal defects by the buttoned device. “buttoned device” clinical trials international register. Heart. 1997;77(3):276–279. doi:https://doi.org/10.1136/hrt.77.3.276. [ published Online First: Epub Date].
   PubMed Web of Science ®Google Scholar
• Janorkar S, Goh T, Wilkinson J. Transcatheter closure of ventricular septal defects using the Rashkind device: initial experience. Catheter Cardiovasc Interv. 1999;46(1):43–48. doi:https://doi.org/10.1002/(sici)1522-726x(199901)46:1<43::aid-ccd12>3.0.co;2-t. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Yang L, Tai BC, Khin LW, Quek SC. A systematic review on the efficacy and safety of transcatheter device closure of ventricular septal defects (VSD). J Interv Cardiol. 2014;27(3):260–272. doi:https://doi.org/10.1111/joic.12121. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Santhanam H, Yang L, Chen Z, Tai BC, Rajgor DD, Quek SC. A meta-analysis of transcatheter device closure of perimembranous ventricular septal defect. Int J Cardiol. 2018;254:75–83. doi:https://doi.org/10.1016/j.ijcard.2017.12.011. [ published Online First: Epub Date].
   PubMed Web of Science ®Google Scholar
• Weryński P, Skorek P, Wójcik A, Rudek-Budzyńska A, Dziewulska A, Rudziński A. Recent achievements in transcatheter closure of ventricular septal defects: a systematic review of literature and a meta-analysis. Kardiol Pol. 2021;79(2):161–169. doi:https://doi.org/10.33963/kp.15708. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Saurav A, Kaushik M, Mahesh Alla V, et al. Comparison of percutaneous device closure versus surgical closure of peri-membranous ventricular septal defects: a systematic review and meta-analysis. Catheter Cardiovasc Interv. 2015;86(6):1048–1056. doi:https://doi.org/10.1002/ccd.26097. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Carminati M, Butera G, Chessa M, et al. Transcatheter closure of congenital ventricular septal defects: results of the European registry. Eur Heart J. 2007;28(19):2361–2368. doi:https://doi.org/10.1093/eurheartj/ehm314. [ published Online First: Epub Date].
   PubMed Web of Science ®Google Scholar
• Predescu D, Chaturvedi RR, Friedberg MK, Benson LN, Ozawa A, Lee KJ. Complete heart block associated with device closure of perimembranous ventricular septal defects. J Thorac Cardiovasc Surg. 2008;136(5):1223–1228. doi:https://doi.org/10.1016/j.jtcvs.2008.02.037. [ published Online First: Epub Date].
   PubMed Web of Science ®Google Scholar
• Holzer R, De Giovanni J, Walsh KP, et al. Transcatheter closure of perimembranous ventricular septal defects using the amplatzer membranous VSD occluder: immediate and midterm results of an international registry. Catheter Cardiovasc Interv. 2006;68(4):620–628. doi:https://doi.org/10.1002/ccd.20659. [ published Online First: Epub Date].
   PubMed Web of Science ®Google Scholar
• Yang R, Kong XQ, Sheng YH, et al. Risk factors and outcomes of post-procedure heart blocks after transcatheter device closure of perimembranous ventricular septal defect. JACC Cardiovasc Interv. 2012;5(4):422–427. doi:https://doi.org/10.1016/j.jcin.2012.01.015. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Butera G, Carminati M, Chessa M, et al. Transcatheter closure of perimembranous ventricular septal defects: early and long-term results. J Am Coll Cardiol. 2007;50(12):1189–1195. doi:https://doi.org/10.1016/j.jacc.2007.03.068. [ published Online First: Epub Date].
   PubMed Web of Science ®Google Scholar
• Wongwaitaweewong K, Promphan W, Roymanee S, Prachasilchai P. Effect of transcatheter closure by Amplatzer(TM) Duct Occluder II in patients with small ventricular septal defect. Cardiovasc Interv Ther. 2021;36(3):375–383. doi:https://doi.org/10.1007/s12928-020-00677-z. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Shrestha M, Promphan W, Layangool T, et al. Feasibility and 1-year outcome of transcatheter closure of perimembranous ventricular septal defects with different devices. Catheter Cardiovasc Interv. 2019;93(1):E30–e37. doi:https://doi.org/10.1002/ccd.27851. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Soufflet V, Van De Bruaene A, Troost E, et al. Behavior of unrepaired perimembranous ventricular septal defect in young adults. Am J Cardiol. 2010;105(3):404–407. doi:https://doi.org/10.1016/j.amjcard.2009.09.047. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Berglund E, Johansson B, Dellborg M, et al. High incidence of infective endocarditis in adults with congenital ventricular septal defect. Heart. 2016;102(22):1835–1839. doi:https://doi.org/10.1136/heartjnl-2015-309133. [ published Online First: Epub Date].
   PubMed Web of Science ®Google Scholar
• Mijangos-Vázquez R, El-Sisi A, Sandoval Jones JP, et al. Transcatheter closure of perimembranous ventricular septal defects using different generations of Amplatzer devices: multicenter experience. J Interv Cardiol. 2020;2020:8948249. doi:https://doi.org/10.1155/2020/8948249. [ published Online First: Epub Date].
   PubMed Web of Science ®Google Scholar
• Li H, Shi Y, Zhang S, et al. Short- and medium-term follow-up of transcatheter closure of perimembranous ventricular septal defects. BMC Cardiovasc Disord. 2019;19(1):222. doi:https://doi.org/10.1186/s12872-019-1188-y. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Esteves CA, Solarewicz LA, Cassar R, Neves JR, Esteves V, Arrieta R. Occlusion of the perimembranous ventricular septal defect using CERA® devices. Catheter Cardiovasc Interv. 2012;80(2):182–187. doi:https://doi.org/10.1002/ccd.24371. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Haas NA, Kock L, Bertram H, et al. Interventional VSD-closure with the Nit-Occlud(®) Lê VSD-Coil in 110 patients: early and midterm results of the EUREVECO-registry. Pediatr Cardiol. 2017;38(2):215–227. doi:https://doi.org/10.1007/s00246-016-1502-8. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Houeijeh A, Godart F, Jalal Z, et al. Transcatheter closure of a perimembranous ventricular septal defect with Nit-Occlud Lê VSD Coil: a French multicentre study. Arch Cardiovasc Dis. 2020;113(2):104–112. doi:https://doi.org/10.1016/j.acvd.2019.11.004. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Nguyen HL, Phan QT, Dinh LH, et al. Nit-Occlud Lê VSD coil versus Duct Occluders for percutaneous perimembranous ventricular septal defect closure. Congenit Heart Dis. 2018;13(4):584–593. doi:https://doi.org/10.1111/chd.12613. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Chen L, Hu S, Luo Z, et al. First-in-human experience with a novel fully bioabsorbable occluder for ventricular septal defect. JACC Cardiovasc Interv. 2020;13(9):1139–1141. doi:https://doi.org/10.1016/j.jcin.2019.09.057. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Holzer R, Balzer D, Cao QL, Lock K, Hijazi ZM. Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: immediate and mid-term results of a U.S. registry. J Am Coll Cardiol. 2004;43(7):1257–1263. doi:https://doi.org/10.1016/j.jacc.2003.10.047. [ published Online First: Epub Date].
   PubMed Web of Science ®Google Scholar
• Arora R, Trehan V, Thakur AK, Mehta V, Sengupta PP, Nigam M. Transcatheter closure of congenital muscular ventricular septal defect. J Interv Cardiol. 2004;17(2):109–115. doi:https://doi.org/10.1111/j.1540-8183.2004.09872.x. [ published Online First: Epub Date].
   Google Scholar
• Morray BH. Ventricular septal defect closure devices, techniques, and outcomes. Interv Cardiol Clin. 2019;8(1):1–10. doi:https://doi.org/10.1016/j.iccl.2018.08.002. [ published Online First: Epub Date].
   Google Scholar
• Hong ZN, Chen Q, Huang LQ, Cao H. A meta-analysis of perventricular device closure of perimembranous ventricular septal defect. J Cardiothorac Surg. 2019;14(1):119. doi:https://doi.org/10.1186/s13019-019-0936-5. [ published Online First: Epub Date].
   Google Scholar
• Fouilloux V, Bonello B, Gran C, Fraisse A, Macé L, Kreitmann B. Perventricular closure of muscular ventricular septal defects in infants with echocardiographic guidance only. World J Pediatr Congenit Heart Surg. 2012;3(4):446–451. doi:https://doi.org/10.1177/2150135112447958. [ published Online First: Epub Date].
   Google Scholar
• Kang SL, Tometzki A, Caputo M, Morgan G, Parry A, Martin R. Longer-term outcome of perventricular device closure of muscular ventricular septal defects in children. Catheter Cardiovasc Interv. 2015;85(6):998–1005. doi:https://doi.org/10.1002/ccd.25821. [ published Online First: Epub Date].
   PubMed Web of Science ®Google Scholar
• Peters B, Ewert P, Berger F. The role of stents in the treatment of congenital heart disease: current status and future perspectives. Ann Pediatr Cardiol. 2009;2(1):3–23. doi:https://doi.org/10.4103/0974-2069.52802. [ published Online First: Epub Date].
   PubMedGoogle Scholar
• Lewis MJ, Kennedy KF, Ginns J, et al. Procedural success and adverse events in pulmonary artery stenting: insights from the NCDR. J Am Coll Cardiol. 2016;67(11):1327–1335. doi:https://doi.org/10.1016/j.jacc.2016.01.025. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Holzer RJ, Gauvreau K, Kreutzer J, et al. Balloon angioplasty and stenting of branch pulmonary arteries: adverse events and procedural characteristics: results of a multi-institutional registry. Circ Cardiovasc Interv. 2011;4(3):287–296. doi:https://doi.org/10.1161/circinterventions.110.961029. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Stapleton GE, Hamzeh R, Mullins CE, et al. Simultaneous stent implantation to treat bifurcation stenoses in the pulmonary arteries: initial results and long-term follow up. Catheter Cardiovasc Interv. 2009;73(4):557–563. doi:https://doi.org/10.1002/ccd.21838. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Narayan HK, Glatz AC, Rome JJ. Bifurcating stents in the pulmonary arteries: a novel technique to relieve bilateral branch pulmonary artery obstruction. Catheter Cardiovasc Interv. 2015;86(4):714–718. doi:https://doi.org/10.1002/ccd.25956. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Krings GJ, van der Stelt F, Molenschot MMC, Breur J. Oval stenting in left pulmonary artery stenosis: a novel double balloon technique to prevent airway compression in single ventricle. EuroIntervention. 2020;15(13):1209–1215. doi:https://doi.org/10.4244/eij-d-18-01079. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Shaffer KM, Mullins CE, Grifka RG, et al. Intravascular stents in congenital heart disease: short- and long-term results from a large single-center experience. J Am Coll Cardiol. 1998;31(3):661–667. doi:https://doi.org/10.1016/s0735-1097(97)00535-4. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Ooi YK, Kim SIH, Gillespie SE, Kim DW, Vincent RN, Petit CJ. Premounted stents for branch pulmonary artery stenosis in children: a short term solution. Catheter Cardiovasc Interv. 2018;92(7):1315–1322. doi:https://doi.org/10.1002/ccd.27800. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Morray BH, McElhinney DB, Marshall AC, Porras D. Intentional fracture of maximally dilated balloon-expandable pulmonary artery stents using ultra-high-pressure balloon angioplasty: a preliminary analysis. Circ Cardiovasc Interv. 2016;9(4):e003281. doi:https://doi.org/10.1161/circinterventions.115.003281. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Zampi JD, Loccoh E, Armstrong AK, et al. Twenty years of experience with intraoperative pulmonary artery stenting. Catheter Cardiovasc Interv. 2017;90(3):398–406. doi:https://doi.org/10.1002/ccd.27094. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Forbes TJ, Kim DW, Du W, et al. Comparison of surgical, stent, and balloon angioplasty treatment of native coarctation of the aorta: an observational study by the CCISC (congenital cardiovascular interventional study consortium). J Am Coll Cardiol. 2011;58(25):2664–2674. doi:https://doi.org/10.1016/j.jacc.2011.08.053. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Hartman EM, Groenendijk IM, Heuvelman HM, Roos-Hesselink JW, Takkenberg JJ, Witsenburg M. The effectiveness of stenting of coarctation of the aorta: a systematic review. EuroIntervention. 2015;11(6):660–668. doi:https://doi.org/10.4244/eijv11i6a133. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Meadows J, Minahan M, McElhinney DB, McEnaney K, Ringel R, Investigators* C. Intermediate outcomes in the prospective, multicenter coarctation of the aorta stent trial (COAST). Circulation. 2015;131(19):1656–1664. doi:https://doi.org/10.1161/CIRCULATIONAHA.114.013937. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Sohrabi B, Jamshidi P, Yaghoubi A, et al. Comparison between covered and bare Cheatham-Platinum stents for endovascular treatment of patients with native post-ductal aortic coarctation: immediate and intermediate-term results. JACC Cardiovasc Interv. 2014;7(4):416–423. doi:https://doi.org/10.1016/j.jcin.2013.11.018. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Chakrabarti S, Kenny D, Morgan G, et al. Balloon expandable stent implantation for native and recurrent coarctation of the aorta–prospective computed tomography assessment of stent integrity, aneurysm formation and stenosis relief. Heart. 2010;96(15):1212–1216. doi:https://doi.org/10.1136/hrt.2009.170928. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Taggart NW, Minahan M, Cabalka AK, Cetta F, Usmani K, Ringel RE. Immediate outcomes of covered stent placement for treatment or prevention of aortic wall injury associated with coarctation of the aorta (COAST II). JACC Cardiovasc Interv. 2016;9(5):484–493. doi:https://doi.org/10.1016/j.jcin.2015.11.038. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Morgan GJ, Ciuffreda M, Spadoni I, DeGiovanni J. Optimus covered stent: advanced covered stent technology for complex congenital heart disease. Congenit Heart Dis. 2018;13(3):458–462. doi:https://doi.org/10.1111/chd.12596. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Promphan W, Han Siang K, Prachasilchai P, et al. Feasibility and early outcomes of aortic coarctation treatments with BeGraft aortic stent. Catheter Cardiovasc Interv. 2020;96(3):E310–e16. doi:https://doi.org/10.1002/ccd.28892. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Haji Zeinali AM, Sadeghian M, Qureshi SA, Ghazi P. Midterm to long-term safety and efficacy of self-expandable nitinol stent implantation for coarctation of aorta in adults. Catheter Cardiovasc Interv. 2017;90(3):425–431. doi:https://doi.org/10.1002/ccd.27178. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Kische S, D’Ancona G, Stoeckicht Y, Ortak J, Elsässer A, Ince H. Percutaneous treatment of adult isthmic aortic coarctation: acute and long-term clinical and imaging outcome with a self-expandable uncovered nitinol stent. Circ Cardiovasc Interv. 2015;8(1). doi:https://doi.org/10.1161/circinterventions.114.001799. [ published Online First: Epub Date].
   Google Scholar
• Boe BA, Armstrong AK, Janse SA, et al. Percutaneous implantation of adult sized stents for coarctation of the aorta in children ≤20 kg: a 12-year experience. Circ Cardiovasc Interv. 2021;14(2):e009399. doi:https://doi.org/10.1161/circinterventions.120.009399. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Shahanavaz S, Aldoss O, Carr K, et al. Acute and medium term results of balloon expandable stent placement in the transverse arch-a multicenter pediatric interventional cardiology early career society study. Catheter Cardiovasc Interv. 2020;96(6):1277–1286. doi:https://doi.org/10.1002/ccd.29248. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Kang SL, Tometzki A, Taliotis D, Martin R. Stent therapy for aortic coarctation in children <30 kg: use of the low profile valeo stent. Pediatr Cardiol. 2017;38(7):1441–1449. doi:https://doi.org/10.1007/s00246-017-1682-x. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Martins JD, Zachariah J, Selamet Tierney ES, et al. Impact of treatment modality on vascular function in coarctation of the aorta: the LOVE - COARCT study. J Am Heart Assoc. 2019;8(7):e011536. doi:https://doi.org/10.1161/jaha.118.011536. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Pieper T, Latus H, Schranz D, et al. Aortic elasticity after aortic coarctation relief: comparison of surgical and interventional therapy by cardiovascular magnetic resonance imaging. BMC Cardiovasc Disord. 2019;19(1):286. doi:https://doi.org/10.1186/s12872-019-01270-w. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Lu WH, Fan CS, Chaturvedi R, Lee KJ, Manlhiot C, Benson L. Clinical impact of stent implantation for coarctation of the aorta with associated hypoplasia of the transverse aortic arch. Pediatr Cardiol. 2017;38(5):1016–1023. doi:https://doi.org/10.1007/s00246-017-1611-z. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Pushparajah K, Sadiq M, Brzezińska-Rajszys G, Thomson J, Rosenthal E, Qureshi SA. Endovascular stenting in transverse aortic arch hypoplasia. Catheter Cardiovasc Interv. 2013;82(4):E491–9. doi:https://doi.org/10.1002/ccd.24735. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Kenny D, Hijazi Z. Bioresorbable stents for pediatric practice: where are we now? Intervent Cardiol. 2015;7(3):245–255. doi:https://doi.org/10.2217/ica.15.6.
   Google Scholar
• Welch TR, Nugent AW, Veeram Reddy SR. Biodegradable stents for congenital heart disease. Interv Cardiol Clin. 2019;8(1):81–94. doi:https://doi.org/10.1016/j.iccl.2018.08.009. [ published Online First: Epub Date].
   Google Scholar
• Ali ZA, Serruys PW, Kimura T, et al. 2-year outcomes with the Absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials with an individual patient data substudy. Lancet. 2017;390(10096):760–772. doi:https://doi.org/10.1016/s0140-6736(17)31470-8. [ published Online First: Epub Date].
   PubMed Web of Science ®Google Scholar
• Hideo-Kajita A, Garcia-Garcia HM, Kolm P, et al. Comparison of clinical outcomes between Magmaris and Orsiro drug eluting stent at 12 months: pooled patient level analysis from BIOSOLVE II-III and BIOFLOW II trials. Int J Cardiol. 2020;300:60–65. doi:https://doi.org/10.1016/j.ijcard.2019.11.003. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Garcia-Garcia HM, Haude M, Kuku K, et al. In vivo serial invasive imaging of the second-generation drug-eluting absorbable metal scaffold (Magmaris - DREAMS 2G) in de novo coronary lesions: insights from the BIOSOLVE-II first-in-man trial. Int J Cardiol. 2018;255:22–28. doi:https://doi.org/10.1016/j.ijcard.2017.12.053. [ published Online First: Epub Date].
   PubMed Web of Science ®Google Scholar
• Sallmon H, Berger F, Cho MY, Opgen-Rhein B. First use and limitations of Magmaris® bioresorbable stenting in a low birth weight infant with native aortic coarctation. Catheter Cardiovasc Interv. 2019;93(7):1340–1343. doi:https://doi.org/10.1002/ccd.28300. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• McCrossan BA, McMahon CJ, Walsh KP. First reported use of drug-eluting bioabsorbable vascular scaffold in congenital heart disease. Catheter Cardiovasc Interv. 2016;87(2):324–328. doi:https://doi.org/10.1002/ccd.25768. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Hehrlein C, Schorch B, Kress N, et al. Zn-alloy provides a novel platform for mechanically stable bioresorbable vascular stents. PLoS One. 2019;14(1):e0209111. doi:https://doi.org/10.1371/journal.pone.0209111. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Shibbani K, De Lima ESBL, Poulin MF, et al. Preclinical comparative assessment of a dedicated pediatric poly-L-lactic-acid-based bioresorbable scaffold with a low-profile bare metal stent. Catheter Cardiovasc Interv. 2020;96(4):878–888. doi:https://doi.org/10.1002/ccd.28893. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Zartner PA, Neudorf U, Bierbach B, Hart C, Schneider MB. First follow-up of a breakable stent for implantation in infants dedicated for a life-long stay. Catheter Cardiovasc Interv. 2018;91(6):1119–1124. doi:https://doi.org/10.1002/ccd.27543. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Quandt D, Knirsch W, Michel-Behnke I, et al. First-in-man pulmonary artery stenting in children using the Bentley® BeGrow™ stent system for newborns and infants. Int J Cardiol. 2019;276:107–109. doi:https://doi.org/10.1016/j.ijcard.2018.11.029. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Guerra AJ, Cano P, Rabionet M, Puig T, Ciurana J. 3D-printed PCL/PLA composite stents: towards a new solution to cardiovascular problems. Materials. 2018;11(9). doi:https://doi.org/10.3390/ma11091679. [ published Online First: Epub Date].
   Google Scholar
• Qiu T, Jiang W, Yan P, Jiao L, Wang X. Development of 3D-printed sulfated chitosan modified bioresorbable stents for coronary artery disease. Front Bioeng Biotechnol. 2020;8:462. doi:https://doi.org/10.3389/fbioe.2020.00462. [ published Online First: Epub Date].
   Google Scholar
• Yeazel TR, Becker ML. Advancing toward 3D printing of bioresorbable shape memory polymer stents. Biomacromolecules. 2020;21(10):3957–3965. doi:https://doi.org/10.1021/acs.biomac.0c01082. [ published Online First: Epub Date].
   Google Scholar
• Bishop ES, Mostafa S, Pakvasa M, et al. 3-D bioprinting technologies in tissue engineering and regenerative medicine: current and future trends. Genes Diseases. 2017;4(4):185–195. doi:https://doi.org/10.1016/j.gendis.2017.10.002. [ published Online First: Epub Date].
   PubMed Web of Science ®Google Scholar
• Lee W, Hong Y, Dai G. 3D bioprinting of vascular conduits for pediatric congenital heart repairs. Transl Res: J Lab Clin Med. 2019;211:35–45. doi:https://doi.org/10.1016/j.trsl.2019.03.007. [ published Online First: Epub Date].
   Google Scholar
• Drews JD, Miyachi H, Shinoka T. Tissue-engineered vascular grafts for congenital cardiac disease: clinical experience and current status. Trends Cardiovasc Med. 2017;27(8):521–531. doi:https://doi.org/10.1016/j.tcm.2017.06.013. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Dhanantwari P, Lee E, Krishnan A, et al. Human cardiac development in the first trimester: a high-resolution magnetic resonance imaging and episcopic fluorescence image capture atlas. Circulation. 2009;120(4):343–351. doi:https://doi.org/10.1161/CIRCULATIONAHA.108.796698. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Allan LD, Sharland G, Tynan MJ. The natural history of the hypoplastic left heart syndrome. Int J Cardiol. 1989;25(3):341–343. doi:https://doi.org/10.1016/0167-5273(89)90226-X.
   Web of Science ®Google Scholar
• Sharland GK, Chita SK, Fagg NL, et al. Left ventricular dysfunction in the fetus: relation to aortic valve anomalies and endocardial fibroelastosis. Br Heart J. 1991;66(6):419–424. doi:https://doi.org/10.1136/hrt.66.6.419.
   Google Scholar
• Freud LR, McElhinney DB, Marshall AC, et al. Fetal aortic valvuloplasty for evolving hypoplastic left heart syndrome: postnatal outcomes of the first 100 patients. Circulation. 2014;130(8):638–645. doi:https://doi.org/10.1161/CIRCULATIONAHA.114.009032. [ published Online First: Epub Date].
   PubMed Web of Science ®Google Scholar
• Jaeggi E, Renaud C, Ryan G, Chaturvedi R. Intrauterine therapy for structural congenital heart disease: contemporary results and Canadian experience. Trends Cardiovasc Med. 2016;26(7):639–646. doi:https://doi.org/10.1016/j.tcm.2016.04.006. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Limperopoulos C, Tworetzky W, McElhinney DB, et al. Brain volume and metabolism in fetuses with congenital heart disease: evaluation with quantitative magnetic resonance imaging and spectroscopy. Circulation. 2010;121(1):26–33. doi:https://doi.org/10.1161/CIRCULATIONAHA.109.865568. [ published Online First: Epub Date].
   PubMed Web of Science ®Google Scholar
• McElhinney DB, Benson CB, Brown DW, et al. Cerebral blood flow characteristics and biometry in fetuses undergoing prenatal intervention for aortic stenosis with evolving hypoplastic left heart syndrome. Ultrasound Med Biol. 2010;36(1):29–37. doi:https://doi.org/10.1016/j.ultrasmedbio.2009.09.004. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Arzt W, Wertaschnigg D, Veit I, Klement F, Gitter R, Tulzer G. Intrauterine aortic valvuloplasty in fetuses with critical aortic stenosis: experience and results of 24 procedures. Ultrasound Obstet Gynecol. 2011;37(6):689–695. doi:https://doi.org/10.1002/uog.8927. [ published Online First: Epub Date].
   PubMed Web of Science ®Google Scholar
• Moon-Grady AJ, Morris SA, Belfort M, et al. International fetal cardiac intervention registry: a worldwide collaborative description and preliminary outcomes. J Am Coll Cardiol. 2015;66(4):388–399. doi:https://doi.org/10.1016/j.jacc.2015.05.037. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Friedman KG, Sleeper LA, Freud LR, et al. Improved technical success, postnatal outcome and refined predictors of outcome for fetal aortic valvuloplasty. Ultrasound Obstet Gynecol. 2018;52(2):212–220. doi:https://doi.org/10.1002/uog.17530. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Kovacevic A, Ohman A, Tulzer G, et al. Fetal hemodynamic response to aortic valvuloplasty and postnatal outcome: a European multicenter study. Ultrasound Obstet Gynecol. 2018;52(2):221–229. doi:https://doi.org/10.1002/uog.18913. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Gardiner HM, Kovacevic A, Tulzer G, et al. Natural history of 107 cases of fetal aortic stenosis from a European multicenter retrospective study. Ultrasound Obstet Gynecol. 2016;48(3):373–381. doi:https://doi.org/10.1002/uog.15876. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Tuo G, Khambadkone S, Tann O, et al. Obstructive left heart disease in neonates with a “borderline” left ventricle: diagnostic challenges to choosing the best outcome. Pediatr Cardiol. 2013;34(7):1567–1576. doi:https://doi.org/10.1007/s00246-013-0685-5. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Hickey EJ, Caldarone CA, Blackstone EH, et al. Critical left ventricular outflow tract obstruction: the disproportionate impact of biventricular repair in borderline cases. J Thorac Cardiovasc Surg. 2007;134(6):1429–36;discussion 36–7. doi:https://doi.org/10.1016/j.jtcvs.2007.07.052. [ published Online First: Epub Date].
   Google Scholar
• Barry OM, Friedman KG, Bergersen L, et al. Clinical and hemodynamic results after conversion from single to biventricular circulation after fetal aortic stenosis intervention. Am J Cardiol. 2018;122(3):511–516. doi:https://doi.org/10.1016/j.amjcard.2018.04.035. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Wilson WM, Valente AM, Hickey EJ, et al. Outcomes of patients with hypoplastic left heart syndrome reaching adulthood after fontan palliation: multicenter study. Circulation. 2018;137(9):978–981. doi:https://doi.org/10.1161/CIRCULATIONAHA.117.031282. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Newburger JW, Sleeper LA, Gaynor JW, et al. Transplant-free survival and interventions at 6 years in the SVR trial. Circulation. 2018;137(21):2246–2253. doi:https://doi.org/10.1161/CIRCULATIONAHA.117.029375. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Dyamenahalli U, McCrindle BW, McDonald C, et al. Pulmonary atresia with intact ventricular septum: management of, and outcomes for, a cohort of 210 consecutive patients. Cardiol Young. 2004;14(3):299–308. doi:https://doi.org/10.1017/S1047951104003087. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Wright LK, Knight JH, Thomas AS, Oster ME, St Louis JD, Kochilas LK. Long-term outcomes after intervention for pulmonary atresia with intact ventricular septum. Heart. 2019;105(13):1007–1013. doi:https://doi.org/10.1136/heartjnl-2018-314124. [ published Online First: Epub Date].
   Google Scholar
• Daubeney PE, Sharland GK, Cook AC, Keeton BR, Anderson RH, Webber SA. Pulmonary atresia with intact ventricular septum: impact of fetal echocardiography on incidence at birth and postnatal outcome. UK and Eire Collaborative Study of Pulmonary Atresia with Intact Ventricular Septum. Circulation. 1998;98:562–566.
   Google Scholar
• Tulzer A, Arzt W, Gitter R, et al. Immediate effects and outcome of in-utero pulmonary valvuloplasty in fetuses with pulmonary atresia with intact ventricular septum or critical pulmonary stenosis. Ultrasound Obstet Gynecol. 2018;52(2):230–237. doi:https://doi.org/10.1002/uog.19047. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Tworetzky W, McElhinney DB, Marx GR, et al. In utero valvuloplasty for pulmonary atresia with hypoplastic right ventricle: techniques and outcomes. Pediatrics. 2009;124(3):e510–8. doi:https://doi.org/10.1542/peds.2008-2014. [ published Online First: Epub Date].
   PubMed Web of Science ®Google Scholar
• Vlahos AP, Lock JE, McElhinney DB, van der Velde ME. Hypoplastic left heart syndrome with intact or highly restrictive atrial septum: outcome after neonatal transcatheter atrial septostomy. Circulation. 2004;109(19):2326–2330. doi:https://doi.org/10.1161/01.CIR.0000128690.35860.C5. [ publishedOnline First: Epub Date].
   PubMed Web of Science ®Google Scholar
• Taketazu M, Barrea C, Smallhorn JF, Wilson GJ, Hornberger LK. Intrauterine pulmonary venous flow and restrictive foramen ovale in fetal hypoplastic left heart syndrome. J Am Coll Cardiol. 2004;43(10):1902–1907. doi:https://doi.org/10.1016/j.jacc.2004.01.033. [ published Online First: Epub Date].
   PubMed Web of Science ®Google Scholar
• Rychik J, Rome JJ, Collins MH, DeCampli WM, Spray TL. The hypoplastic left heart syndrome with intact atrial septum: atrial morphology, pulmonary vascular histopathology and outcome. J Am Coll Cardiol. 1999;34(2):554–560. doi:https://doi.org/10.1016/S0735-1097(99)00225-9.
   PubMed Web of Science ®Google Scholar
• Marshall AC, Levine J, Morash D, et al. Results of in utero atrial septoplasty in fetuses with hypoplastic left heart syndrome. Prenat Diagn. 2008;28(11):1023–1028. doi:https://doi.org/10.1002/pd.2114. [ published Online First: Epub Date].
   PubMed Web of Science ®Google Scholar
• Glatz JA, Tabbutt S, Gaynor JW, et al. Hypoplastic left heart syndrome with atrial level restriction in the era of prenatal diagnosis. Ann Thorac Surg. 2007;84(5):1633–1638. doi:https://doi.org/10.1016/j.athoracsur.2007.06.061. [ published Online First: Epub Date].
   PubMed Web of Science ®Google Scholar
• Vida VL, Bacha EA, Larrazabal A, et al. Hypoplastic left heart syndrome with intact or highly restrictive atrial septum: surgical experience from a single center. Ann Thorac Surg. 2007;84(2):581–585. discussion 86. doi:https://doi.org/10.1016/j.athoracsur.2007.04.017. [ published Online First: Epub Date].
   PubMed Web of Science ®Google Scholar
• Anwar SSG, Miller J, Sharma M, et al. 3D printing is a transformative technology in congenital heart disease. JACC Basic Trans Sci. 2018;3(2):294–312. doi:https://doi.org/10.1016/j.jacbts.2017.10.003.
   Google Scholar
• Illmann CF, Ghadiry-Tavi R, Hosking M, Harris KC. Utility of 3D printed cardiac models in congenital heart disease: a scoping review. Heart. 2020;106(21):1631–1637. doi:https://doi.org/10.1136/heartjnl-2020-316943. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Pluchinotta FR, Sturla F, Caimi A, et al. 3-Dimensional personalized planning for transcatheter pulmonary valve implantation in a dysfunctional right ventricular outflow tract. Int J Cardiol. 2020;309:33–39. doi:https://doi.org/10.1016/j.ijcard.2019.12.006. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Ong CS, Krishnan A, Huang CY, et al. Role of virtual reality in congenital heart disease. Congenit Heart Dis. 2018;13(3):357–361. doi:https://doi.org/10.1111/chd.12587. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Kasprzak JD, Pawlowski J, Peruga JZ, Kaminski J, Lipiec P. First-in-man experience with real-time holographic mixed reality display of three-dimensional echocardiography during structural intervention: balloon mitral commissurotomy. Eur Heart J. 2020;41(6):801. doi:https://doi.org/10.1093/eurheartj/ehz127. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Bruckheimer E, Rotschild C, Dagan T, et al. Computer-generated real-time digital holography: first time use in clinical medical imaging. Eur Heart J Cardiovasc Imaging. 2016;17(8):845–849. doi:https://doi.org/10.1093/ehjci/jew087. [ published Online First: Epub Date].
   PubMed Web of Science ®Google Scholar
• Jone PN, Haak A, Ross M, et al. Congenital and structural heart disease interventions using echocardiography-fluoroscopy fusion imaging. J Am Soc Echocardiogr. 2019;32(12):1495–1504. doi:https://doi.org/10.1016/j.echo.2019.07.023. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Capelli C, Sauvage E, Giusti G, et al. Patient-specific simulations for planning treatment in congenital heart disease. Interface Focus. 2018;8(1):20170021. doi:https://doi.org/10.1098/rsfs.2017.0021. [ published Online First: Epub Date].
   Web of Science ®Google Scholar
• Caimi A, Sturla F, Pluchinotta FR, et al. Prediction of stenting related adverse events through patient-specific finite element modelling. J Biomech. 2018;79:135–146. doi:https://doi.org/10.1016/j.jbiomech.2018.08.006. [ published Online First: Epub Date].
   Web of Science ®Google Scholar